Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2416 first-in-human phase I study in healthy Japanese men
jRCT2071250147Phase 1Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ONO-2416 (8 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Safety and tolerability and Pharmacokinetics. Started Apr 2026; status: recruiting.
02
Drugs
ONO-2416
Beyond the preview
Go deeper on jRCT2071250147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250147.